Debt And LeverageWith net leverage continuing to come down, M&A could re-emerge as a tailwind to topline and earnings growth over time.
Execution RisksPositive demand trends in MIR’s nuclear power and nuclear medicine end markets coupled with the company’s increasingly focused execution could position to deliver vs. its recently established targets.
Market CompetitionMIR Medical strategy seems to be maturing in Medical where increased focus on integrating software with hardware, continued emphasis on independent quality assurance, and greater focus on lean/value analysis and value engineering should drive continued improvements in MIR Medical’s performance.